Roche faces high fines for excessive pricing

The Competition Commission of South Africa has asked the country’s specialist tribunal to fine Roche and two of its subsidiaries for excessively pricing a life-saving breast cancer treatment drug for nearly a decade.

Get unlimited access to all Global Competition Review content